MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 139 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,858 | -38.1% | 26,410 | -2.2% | 0.00% | -50.0% |
Q2 2023 | $6,235 | -64.7% | 26,991 | -63.0% | 0.00% | -50.0% |
Q1 2023 | $17,669 | -30.7% | 72,935 | -17.0% | 0.01% | -27.3% |
Q4 2022 | $25,503 | -99.1% | 87,868 | +102.4% | 0.01% | +266.7% |
Q3 2022 | $2,821,000 | +415.7% | 43,415 | +468.3% | 0.00% | – |
Q2 2022 | $547,000 | -40.2% | 7,639 | -18.0% | 0.00% | -100.0% |
Q1 2022 | $914,000 | -63.2% | 9,315 | -68.2% | 0.00% | – |
Q4 2021 | $2,482,000 | +68.2% | 29,292 | +58.2% | 0.00% | -100.0% |
Q3 2021 | $1,476,000 | -8.5% | 18,513 | +11.8% | 0.00% | 0.0% |
Q2 2021 | $1,613,000 | -28.1% | 16,561 | -13.6% | 0.00% | 0.0% |
Q1 2021 | $2,242,000 | +25.8% | 19,168 | +19.6% | 0.00% | 0.0% |
Q4 2020 | $1,782,000 | -13.0% | 16,029 | -7.1% | 0.00% | 0.0% |
Q3 2020 | $2,049,000 | -8.9% | 17,262 | -13.0% | 0.00% | -50.0% |
Q2 2020 | $2,248,000 | +82.9% | 19,837 | +7.8% | 0.00% | +100.0% |
Q1 2020 | $1,229,000 | +1.7% | 18,398 | +38.9% | 0.00% | 0.0% |
Q4 2019 | $1,208,000 | +215.4% | 13,244 | +197.8% | 0.00% | – |
Q3 2019 | $383,000 | -27.5% | 4,448 | -11.8% | 0.00% | – |
Q2 2019 | $528,000 | -75.0% | 5,041 | -70.1% | 0.00% | -100.0% |
Q1 2019 | $2,110,000 | -54.9% | 16,848 | -59.4% | 0.00% | -75.0% |
Q4 2018 | $4,678,000 | -28.2% | 41,502 | +36.4% | 0.00% | 0.0% |
Q3 2018 | $6,516,000 | -3.1% | 30,430 | +26.5% | 0.00% | -33.3% |
Q2 2018 | $6,726,000 | +76.3% | 24,046 | -26.4% | 0.01% | +100.0% |
Q1 2018 | $3,815,000 | +2952.0% | 32,670 | +2293.4% | 0.00% | – |
Q4 2017 | $125,000 | +3025.0% | 1,365 | +1307.2% | 0.00% | – |
Q3 2017 | $4,000 | -50.0% | 97 | -80.0% | 0.00% | – |
Q2 2017 | $8,000 | – | 485 | +12025.0% | 0.00% | – |
Q1 2017 | $0 | – | 4 | 0.0% | 0.00% | – |
Q4 2016 | $0 | – | 4 | 0.0% | 0.00% | – |
Q3 2016 | $0 | – | 4 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |